Program
Thursday, 20 February 2025
| 12.00 | Registration |
| 13.00 | Welcome |
| 13.15 | Keynote Limitations for LTX in metabolic diseases René Santer (Hamburg) |
| Longterm outcome after liver transplantation - Part 1 |
|
| 13.45 | Post-LTX metabolism in MMA and other organic aciduria Carlo Dionisi-Vici (Rome) |
| 14.15 | Longterm outcome after LTX incl. quality of life Martina Sterneck, Louisa Lund (Hamburg) |
| Longterm outcome after liver transplantation - Part 2 |
|
| 14.45 | Longterm cancer risk under immunosuppression Wilhelm Wößmann (Hamburg) |
| 15.15 | Transition in care: balancing between evidence and good care Anneloes van Staa (Rotterdam) |
| 15.45 | Coffee Break | Industry Exhibition |
| 16.15 | IPSEN Industry symposium Every baby deserves a genetic screening? |
| 16.45 | Neonatal cholestasis to be announced |
| 18.00 | End of day |
| 19.00 | Congress dinner |
Friday, 21 February 2025
| 08.30 | Welcome |
| 08.45 | Keynote Biliary atresia Claus Petersen (Hanover) |
| 09.15 | BARD Session on biliary atresia Podium discussion on when to go for transplantation Ricardo Superina (Chicago), Mark Davenport (London) |
| 10.00 | Coffee Break | Industry Exhibition |
| 10.30 | The hepatologists‘ view on biliary atresia Henkjan Verkade (Groningen) |
| 11.00 | 20 years national centralization of BA care Mikko Pakarinen (Helsinki) |
| 11.30 | MIRUM Industry symposium Unveiling the hidden signals: Biomarkers and symptoms in neonatal cholestasis Interactive case Session & discussion |
| 12.30 | Lunch Break | Industry Exhibition |
| 13.15 | Wilson‘s disease New diagnostic tools and therapeutic innovation Isabelle Mohr (Heidelberg) Interactive case session & discussion |
| 14.15 | To be announced |
| 15.15 | ERN activities and registries
ERN Rare Liver |
| 16.00 | Farewell |